| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/12/2005 | EP1583536A2 Method of treatment of prostate cancer and composition for treatment thereof |
| 10/12/2005 | EP1583524A1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 10/12/2005 | EP1583523A1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 10/12/2005 | EP1583522A1 Use of cyclin d1 inhibitors |
| 10/12/2005 | EP1583521A1 Use of hypericin and/or the derivatives thereof for the prevention of primary tumours |
| 10/12/2005 | EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 10/12/2005 | EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 10/12/2005 | EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors |
| 10/12/2005 | EP1359943B1 Biotin-derivates and their conjugates with chelating agents |
| 10/12/2005 | EP1309579B1 Inhibitors of matrix metalloproteinases |
| 10/12/2005 | EP1294918B1 Replication deficient adenoviral tnf vector |
| 10/12/2005 | EP1272195B1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/12/2005 | EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 10/12/2005 | EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 10/12/2005 | EP1185249B1 Use of a biodegradable polymer |
| 10/12/2005 | EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6 |
| 10/12/2005 | EP1163219B1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
| 10/12/2005 | EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha |
| 10/12/2005 | EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity |
| 10/12/2005 | EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 10/12/2005 | EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 10/12/2005 | EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 10/12/2005 | CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 10/12/2005 | CN1681833A Sir2 products and activities |
| 10/12/2005 | CN1681824A A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 10/12/2005 | CN1681818A Azaindole kinase inhibitors |
| 10/12/2005 | CN1681817A Biologically active compounds |
| 10/12/2005 | CN1681816A Novel pyrazolopyridines as cyclin dependent kinase inhibitors |
| 10/12/2005 | CN1681813A Synthesis of indolizines |
| 10/12/2005 | CN1681811A Azolidinone-vinyl fused-benzene derivatives |
| 10/12/2005 | CN1681810A Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors |
| 10/12/2005 | CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors |
| 10/12/2005 | CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 10/12/2005 | CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 10/12/2005 | CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 10/12/2005 | CN1681770A Amino-propanol derivatives |
| 10/12/2005 | CN1681558A Platinum complexes as antitumor agents in combination with biochemical modulation |
| 10/12/2005 | CN1681557A Methods for treating carbonic anhydrase mediated disorders |
| 10/12/2005 | CN1681528A Use of urease for inhibiting cancer cell growth |
| 10/12/2005 | CN1681515A Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor |
| 10/12/2005 | CN1681513A Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 10/12/2005 | CN1681511A Combinations of drugs for the treatment of neoplasms |
| 10/12/2005 | CN1681508A Novel inhibitors of kinases |
| 10/12/2005 | CN1681505A Combination of a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia |
| 10/12/2005 | CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE) |
| 10/12/2005 | CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors |
| 10/12/2005 | CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 10/12/2005 | CN1681495A Combination therapy for hyperplasia diseases |
| 10/12/2005 | CN1681489A Combination of chemotherapeutic drugs for increasing antitumor activity |
| 10/12/2005 | CN1680438A Human pifl gene, its coding protein and use thereof |
| 10/12/2005 | CN1680431A Crystal of human avidin protein and preparation thereof |
| 10/12/2005 | CN1680424A Preparation and use for active saponin |
| 10/12/2005 | CN1680410A Platinum(II) complex with alkoxy carboxylic acid as ligand and antineoplastic characteristic |
| 10/12/2005 | CN1680409A Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid |
| 10/12/2005 | CN1680402A Water soluble prodrugs of hindered alcohols |
| 10/12/2005 | CN1680390A Halogenated dihydroartemisine, preparation and use thereof |
| 10/12/2005 | CN1680384A Norcantharidin platinum complex and its use |
| 10/12/2005 | CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives |
| 10/12/2005 | CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives |
| 10/12/2005 | CN1680372A New benzo[b]chromeno-naphthyridin-7-one and pyrano[2', 3':7, 8] quino[2, 3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them |
| 10/12/2005 | CN1680370A Epothilones C, and its preparation and use as cell inhibitor |
| 10/12/2005 | CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels |
| 10/12/2005 | CN1680358A Composition concerned with isoflavone and the similar and therapeutical method |
| 10/12/2005 | CN1680353A Rice bean flavone extracts and their use |
| 10/12/2005 | CN1680336A New imidazole derivative, method for producing the same and use of the same |
| 10/12/2005 | CN1680334A Fused pyrazolyls |
| 10/12/2005 | CN1680333A Anti-virus pyrazole derivatives |
| 10/12/2005 | CN1680313A Farnesyl transferase inhibitors |
| 10/12/2005 | CN1680304A Lingshui alcohol with anti-cancer activity, its preparation and use |
| 10/12/2005 | CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 10/12/2005 | CN1680270A 3, 4, 5,-substituted benzyl ethylene derivatives and their preparation and use |
| 10/12/2005 | CN1680252A C60 trans-succinate with biologic activity and its synthesis |
| 10/12/2005 | CN1680248A Use of 2', 4'-dihydroxy-6'-methoxy-3', 5'-dimethyl chalkone as reversing agent for resistance of multiple tumours drugs |
| 10/12/2005 | CN1679970A Preparation of radiative immune guiding operating medicine of colorectal disease |
| 10/12/2005 | CN1679964A Antisense nucleic acid medicine composition with bcr3/abl2 and VEGF gene function inhibition and use thereof |
| 10/12/2005 | CN1679952A Anticarcinogenic medicine composition |
| 10/12/2005 | CN1679951A Medicinal composition for tumor body |
| 10/12/2005 | CN1679950A Anticarcinogenic internal implant agent |
| 10/12/2005 | CN1679949A Anticarcinogenic internal implant agent |
| 10/12/2005 | CN1679948A Anticarcinogenic internal implant agent |
| 10/12/2005 | CN1679947A Anticarcinogen composition |
| 10/12/2005 | CN1679946A Anticarcinogen composition |
| 10/12/2005 | CN1679945A Anticarcinogen composition |
| 10/12/2005 | CN1679944A Anticarcinogen composition |
| 10/12/2005 | CN1679938A Pharmaceutical compositions |
| 10/12/2005 | CN1679937A Compositions and methods for treating or preventing inflammatory diseases |
| 10/12/2005 | CN1679936A Anticarcinogen composition |
| 10/12/2005 | CN1679934A Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 10/12/2005 | CN1679932A Ordered molecular presentation of antigens, method of preparation and use |
| 10/12/2005 | CN1679930A Human papilloma virus and heat shock protein recombinant protein vaccine and use thereof |
| 10/12/2005 | CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist |
| 10/12/2005 | CN1679915A Peptide antagonists of zonulin and methods for use of the same |
| 10/12/2005 | CN1679912A Extraction of liuwei Dihuang polysaccharide, products and use thereof |
| 10/12/2005 | CN1679911A Process for producing a culture of antrodia camphorata and product obtained thereby |
| 10/12/2005 | CN1679908A Chinese medicine for treating tumor and preparation thereof |
| 10/12/2005 | CN1679899A Chinese medicine capsules for treating primary hepatocarcinoma and preparation thereof |
| 10/12/2005 | CN1679898A Chinese medicine composition for treating hepatitis and cancers |
| 10/12/2005 | CN1679892A Oral liquid for treating cancer and preparation thereof |
| 10/12/2005 | CN1679889A Medicine for inhibiting and eliminating cancer |
| 10/12/2005 | CN1679883A Compound light-yellow sophora root freeze-drying injection and preparation thereof |